NUTRA PHARMA CORP. (NPHC) Gross margin 2016–2025
NUTRA PHARMA CORP. (NPHC) gross margin by fiscal year — reported gross profit divided by reported revenue.
76.3%FY2025 · since FY2016: -32.5% → 76.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 76.3% | -24.1 pp |
| FY2024 | 100.4% | -92.5 pp |
| FY2023 | 192.9% | +22.1 pp |
| FY2022 | 170.8% | +162.1 pp |
| FY2021 | 8.7% | -20.1 pp |
| FY2020 | 28.7% | -4.5 pp |
| FY2019 | 33.3% | +22.5 pp |
| FY2018 | 10.8% | -67.0 pp |
| FY2017 | 77.8% | +110.2 pp |
| FY2016 | -32.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice